Genmab A/S (GMAB) Announces Submissions of Regulatory Applications for Epcoritamab for Relapsed/Refractory LBCL and DLBCL

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. SPG

Go back to Genmab A/S (GMAB) Announces Submissions of Regulatory Applications for Epcoritamab for Relapsed/Refractory LBCL and DLBCL
AbbVie (NYSE: ABBV) Delayed: 256.46 -3.75 (1.44%)
Previous Close $260.21    52 Week High $68.12 
Open $257.96    52 Week Low $50.71 
Day High $258.91    P/E 55.63 
Day Low $255.58    EPS $4.61 
Volume 4,729,804       

(NASDAQ: GMAB) Delayed: 33.60 -0.81 (2.35%)
Previous Close $34.41    52 Week High $ 
Open $33.96    52 Week Low $ 
Day High $34.19    P/E N/A 
Day Low $33.55    EPS $ 
Volume 1,002,606